ADGN-903

N/A

Report date: 2025/06/11 10:41:33
NME

Base Information

Drug NameADGN-903
Drug Alias NameADGN-9xx
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionDNA repair inhibitorsBreast cancer type 1 susceptibility protein stimulants
TargetsBreast cancer type 1 susceptibility protein
Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAanastra Inc
China Registration ClassN/A

Develop Information

Active CompaniesDIVINCELL SASAanastra Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A